Radiopharmaceutical Supply Disruptions and the Use of Tc-hydroxymethylene Diphosphonate As an Alternative to Tc-pyrophosphate for the Diagnosis of Transthyretin Cardiac Amyloidosis: An ASNC Information Statement

Overview

Journal J Nucl Cardiol

Specialty Cardiology & Vascular Diseases

Date 2022 Jul 15

PMID 35838892

Authors

Edward J Miller

Roxana Campisi

Nishant R Shah

Sean McMahon

Sarah Cuddy

Cesia Gallegos-Kattan

Mathew S Maurer

Thibaud Damy

Riemer H J A Slart

Ketan Bhatia

Andrew J Einstein

Affiliations

Soon will be listed here.

Citing Articles

Advances in Cardiac Imaging and Genetic Testing for Diagnosis and Risk Stratification in Cardiomyopathies: 2024 Update.

Gasior T J Clin Med. 2024; 13(23).

PMID: 39685624 PMC: 11642006. DOI: 10.3390/jcm13237166.

The Role of Multimodality Imaging in Cardiomyopathy.

Pan J, Patel A Curr Cardiol Rep. 2024; 26(7):689-703.

PMID: 38753290 PMC: 11236518. DOI: 10.1007/s11886-024-02068-9.

Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases.

Chan N, Einstein A, Griffin J, Rosenblum H, Teruya S, Cuomo M J Nucl Cardiol. 2023; 30(6):2531-2539.

PMID: 37311914 DOI: 10.1007/s12350-023-03310-7.

References

Gillmore J, Maurer M, Falk R, Merlini G, Damy T, Dispenzieri A . Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016; 133(24):2404-12. DOI: 10.1161/CIRCULATIONAHA.116.021612. View

Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A . Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur J Heart Fail. 2021; 23(4):512-526. DOI: 10.1002/ejhf.2140. View

Galat A, Rosso J, Guellich A, Van Der Gucht A, Rappeneau S, Bodez D . Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis. Amyloid. 2015; 22(4):210-20. DOI: 10.3109/13506129.2015.1072089. View

Parkey R, BONTE F, Meyer S, Atkins J, Curry G, Stokely E . A new method for radionuclide imaging of acute myocardial infarction in humans. Circulation. 1974; 50(3):540-6. DOI: 10.1161/01.cir.50.3.540. View

Cappelli F, Gallini C, Di Mario C, Costanzo E, Vaggelli L, Tutino F . Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis. J Nucl Cardiol. 2017; 26(2):497-504. DOI: 10.1007/s12350-017-0922-z. View

Maurer M . Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology. Am J Med. 2015; 128(12):1275-80. PMC: 4798849. DOI: 10.1016/j.amjmed.2015.05.039. View

Hanna M, Ruberg F, Maurer M, Dispenzieri A, Dorbala S, Falk R . Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week. J Am Coll Cardiol. 2020; 75(22):2851-2862. DOI: 10.1016/j.jacc.2020.04.022. View

Van Der Gucht A, Cottereau A, Abulizi M, Guellich A, Blanc-Durand P, Israel J . Apical sparing pattern of left ventricular myocardial Tc-HMDP uptake in patients with transthyretin cardiac amyloidosis. J Nucl Cardiol. 2017; 25(6):2072-2079. DOI: 10.1007/s12350-017-0894-z. View

Flaherty K, Morgenstern R, Pozniakoff T, DeLuca A, Castano A, Maurer M . Technetium pyrophosphate scintigraphy with cadmium zinc telluride cameras is a highly sensitive and specific imaging modality to diagnose transthyretin cardiac amyloidosis. J Nucl Cardiol. 2019; 27(2):371-380. DOI: 10.1007/s12350-019-01831-8. View

10.

Cuscaden C, Ramsay S, Prasad S, Goodwin B, Smith J . Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation. J Nucl Cardiol. 2020; 28(6):2845-2856. DOI: 10.1007/s12350-020-02152-x. View

11.

Maurer M, Schwartz J, Gundapaneni B, Elliott P, Merlini G, Waddington-Cruz M . Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2018; 379(11):1007-1016. DOI: 10.1056/NEJMoa1805689. View

12.

Musumeci M, Cappelli F, Russo D, Tini G, Canepa M, Milandri A . Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2019; 13(6):1314-1321. DOI: 10.1016/j.jcmg.2019.10.015. View

13.

Cappelli F, Gallini C, Costanzo E, Tutino F, Ciaccio A, Vaggelli L . Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon. Int J Cardiol. 2018; 254:346-350. DOI: 10.1016/j.ijcard.2017.10.027. View

14.

Rapezzi C, Gagliardi C, Milandri A . Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis. J Nucl Cardiol. 2018; 26(5):1638-1641. DOI: 10.1007/s12350-018-1235-6. View

15.

Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk R, Ferrari V . ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol. 2019; 26(6):2065-2123. DOI: 10.1007/s12350-019-01760-6. View

16.

Malka N, Abulizi M, Kharoubi M, Oghina S, Galat A, Le Bras F . Extracardiac soft tissue uptake, evidenced on early Tc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value. Eur J Nucl Med Mol Imaging. 2020; 47(10):2396-2406. DOI: 10.1007/s00259-020-04753-7. View

17.

Bokhari S, Castano A, Pozniakoff T, Deslisle S, Latif F, Maurer M . (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging. 2013; 6(2):195-201. PMC: 3727049. DOI: 10.1161/CIRCIMAGING.112.000132. View

18.

Bellevre D, Bailliez A, Delelis F, Blaire T, Agostini D, Mouquet F . Quantitation of myocardial Tc-HMDP uptake with new SPECT/CT cadmium zinc telluride (CZT) camera in patients with transthyretin-related cardiac amyloidosis: Ready for clinical use?. J Nucl Cardiol. 2020; 29(2):506-514. DOI: 10.1007/s12350-020-02274-2. View

19.

Galat A, Van Der Gucht A, Guellich A, Bodez D, Cottereau A, Guendouz S . Early Phase Tc-HMDP Scintigraphy for the Diagnosis and Typing of Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2016; 10(5):601-603. DOI: 10.1016/j.jcmg.2016.05.007. View

20.

Ruberg F, Grogan M, Hanna M, Kelly J, Maurer M . Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019; 73(22):2872-2891. PMC: 6724183. DOI: 10.1016/j.jacc.2019.04.003. View